The global Cancer Biopsy market was valued at USD 30.2 billion in 2023 and is projected to reach USD 56.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period 2024-2031.
Market Analysis
The growth of the Cancer Biopsy market is driven by:
- Increasing prevalence of cancer worldwide, necessitating accurate diagnostic methods.
- Advancements in biopsy techniques and technologies improving accuracy and reliability.
- Rising adoption of minimally invasive biopsy procedures enhancing patient comfort and recovery.
Download Your No-Cost Sample Report: https://www.snsinsider.com/sample-request/1759
Key Players
Major companies in the Cancer Biopsy market include:
- Roche Diagnostics
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Agilent Technologies, Inc.
- Siemens Healthineers AG
- Myriad Genetics, Inc.
Market Segmentation
By Product
- Instruments
- Kits And Consumables
- Services
By Type
- Tissue Biopsies
- Needle Biopsies
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Surgical Biopsies
- Liquid Biopsies
- Others
By Application
- Breast Cancer
- Colorectal Cancer
- Cervical Cancers
- Lung Cancers
- Prostate Cancers
- Skin Cancers
- Blood Cancers
- Kidney Cancers
- Liver Cancers
- Pancreatic Cancers
- Ovarian Cancers
- Others
Regional Analysis
North America is expected to dominate the Cancer Biopsy market, owing to advanced healthcare infrastructure and high prevalence of cancer. Europe and Asia Pacific regions are anticipated to witness significant growth due to increasing awareness and improving healthcare facilities.
Key Takeaways
- The Cancer Biopsy market is poised for substantial growth driven by the increasing incidence of cancer and advancements in biopsy technologies.
- Minimally invasive biopsy techniques are gaining preference due to their lower risk and faster recovery times.
- Strategic partnerships and product innovations among key market players are expected to enhance market competitiveness.
Make Enquiry About Cancer Biopsy Market Report: https://www.snsinsider.com/enquiry/1759
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Cancer Biopsy Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Cancer Biopsy Market Segmentation, By Therapy Type
Chapter 9 Cancer Biopsy Market Segmentation, By Cancer Type
Chapter 10 Cancer Biopsy Market Segmentation, By Distribution Channel
Chapter 11 Cancer Biopsy Market – Regional Analysis
Chapter 12 Company profile
Chapter 13 Competitive Landscape
Chapter 14 Use Case and Best Practices
Chapter 15 Conclusion
Access This Full Report with Charts And Graphs @ https://www.snsinsider.com/reports/cancer-biopsy-market-1759
About Us
SNS Insider is a leading market research and consulting agency providing comprehensive insights into global markets. We specialize in delivering accurate market data and strategic recommendations to our clients worldwide.
Contact Us
Akash Anand – Head of Business Development & Strategy
Email: info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: SNS Insider
